AstraZeneca, a British pharmaceutical giant, has admitted that its Covid-19 vaccine can result ina rare side effectknown as Thrombosis with Thrombocytopenia Syndrome (TTS).T
British pharmaceutical giant AstraZeneca has acknowledged that its Covid vaccine can lead to a rare blood clotting condition known as Thrombosis with Thrombocytopenia Syndrome (TTS)
Covishield TTS: AstraZeneca has acknowledged the potential TTS side effects from its COVID-19 vaccine Covishield, used widely in India. TTS, Thrombosis with Thrombocytopenia Syndrome, is rare but serious, marked by blood clots and low platelet levels. Symptoms include headaches, blurred vision, and chest pain. Dr. Jayadevan emphasizes awareness, stressing early treatment for effective management. AstraZeneca s admission follows reports of TTS linked to adenovirus vector vaccines.
AstraZeneca (AZ) has admitted its Covid vaccine may cause Thrombosis with Thrombocytopenia Syndrome (TTS). Know all about the rare side effect. | Health